纳豆激酶通过活性尿激酶原(内生)增强胞浆素。
B. Nattokinase enhances plasmin through active pro-urokinase (endogenous).
目的构建纳豆激酶原基因克隆,实现其在大肠杆菌中的表达。
Purpose Molecular cloning and expression of pro nattokinase gene with e.
方法从纳豆芽胞杆菌中分离纯化基因组DNA ,作为模板通过PCR扩增纳豆激酶原基因。
Methods Chromosome DNA was isolated from Bacillus natto . The pro nattokinase gene was then amplified from chromosome by PCR.
据报道,纳豆激酶有和胞浆素一样的可直接分解纤维蛋白的生物特性,或者增强尿激酶原和t—PA(人组织型纤溶酶原激活剂)的活性。
According to reports, Nattokinase has plasmin-like bio-characteristic that lyses fibrin directly, or increases activity of pro-urokinase and t-PA (Tissue Plasminogen Activator).
尿激酶是一种纤溶酶原激活剂,临床上用于治疗血栓。
Urokinase, a human plasminogen activator, is used clinically to promote the dissolution of thrombi.
纤溶酶原和尿激酶前体的相互活化作用在纤溶的开始和加速上发挥着重要的作用。
Reciprocal activation of prourokinase and plasminogen is an important mechanism in the initiation and propagation of local fibrinolytic activity.
目的:探讨尿激酶型纤溶酶原激活因子的蛋白表达与上皮性卵巢癌生物学行为的关系。
Objective: To identify the significance of urokinase-type plasminogen activator expression in patients with epithelial ovarian carcinoma.
本文用尿激酶(UK)和人体组织型纤溶酶原激活剂(t - PA)进行了兔髂股动脉血栓实验性溶解的对照研究。
The thrombolytic effect was compared between urokinase (UK) and human tissue plasminogen activator (t-PA) in rabbits with experimental iliofemoral artery thrombus.
从脑片染色结果及给药后不同时间点大鼠血液中纤溶酶原激活剂和其抑制剂的含量变化显示用该工艺纯化的蚓激酶有较好的溶栓作用。
The EFE purified through the process mentioned above has high specific activity and good effect in treating cerebral ischemia. Concerntration oft-PA and PAI, in respect of the rats in…
从脑片染色结果及给药后不同时间点大鼠血液中纤溶酶原激活剂和其抑制剂的含量变化显示用该工艺纯化的蚓激酶有较好的溶栓作用。
The EFE purified through the process mentioned above has high specific activity and good effect in treating cerebral ischemia. Concerntration oft-PA and PAI, in respect of the rats in…
应用推荐